Clinical Trial Update: Influence of Plasma Rich in Growth Factors (PRGF) on Healing of Medial Collateral Ligament (MCL) Tear [Phase 2, Phase 3]

View source ↗

Summary

The Phase 2/3 clinical trial evaluating Plasma Rich in Growth Factors (PRGF) for healing of a medial collateral ligament tear has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Medial Collateral Ligament Tear

Drugs mentioned

• Plasma Rich in Growth Factors (PRGF)

Snippet

Sponsor: Meir Medical Center | Conditions: MCL Tear | Phase 2, Phase 3 | Status: WITHDRAWN